malondialdehyde has been researched along with Affective Disorders in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 2 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Auxilia, AM; Buoli, M; Caldiroli, A; Capuzzi, E; Clerici, M | 1 |
| Ayadi, F; Ben Thabet, J; Charfi, N; Grayaa, S; Guidara, W; Maalej, M; Messedi, M; Naifar, M; Omri, S | 1 |
| Anderson, G; Barbosa, DS; Bonifacio, KL; Carvalho, AF; de Melo, LGP; Drozdstoj, S; Maes, M; Moraes, JB; Moreira, E; Nunes, CS; Nunes, SOV; Roomruangwong, C; Vargas, HO | 1 |
| Costa E Silva, J; Kalia, M | 1 |
2 review(s) available for malondialdehyde and Affective Disorders
| Article | Year |
|---|---|
Malondialdehyde and bipolar disorder: A short comprehensive review of available literature.
Topics: Bipolar Disorder; Humans; Malondialdehyde; Mood Disorders; Oxidative Stress; Thiobarbituric Acid Reactive Substances | 2020 |
Biomarkers of psychiatric diseases: current status and future prospects.
Topics: Acetyltransferases; Alzheimer Disease; Biomarkers; Bipolar Disorder; Brain; Brain-Derived Neurotrophic Factor; C-Reactive Protein; Cytokines; Depressive Disorder, Major; Dopamine; gamma-Aminobutyric Acid; History, 20th Century; Humans; Isoprostanes; Malondialdehyde; Mental Disorders; Mood Disorders; Neopterin; Neurofibrillary Tangles; S100 Calcium Binding Protein beta Subunit; Schizophrenia; Suicidal Ideation | 2015 |
2 other study(ies) available for malondialdehyde and Affective Disorders
| Article | Year |
|---|---|
Predictive value of oxidative stress biomarkers in drug‑free patients with schizophrenia and schizo-affective disorder.
Topics: Adult; Advanced Oxidation Protein Products; Biomarkers; Case-Control Studies; Female; Glutathione; Glutathione Peroxidase; Humans; Male; Malondialdehyde; Middle Aged; Mood Disorders; Oxidation-Reduction; Oxidative Stress; Psychotic Disorders; ROC Curve; Schizophrenia; Sensitivity and Specificity; Tunisia | 2020 |
Lowered quality of life in mood disorders is associated with increased neuro-oxidative stress and basal thyroid-stimulating hormone levels and use of anticonvulsant mood stabilizers.
Topics: Adult; Adult Survivors of Child Adverse Events; Advanced Oxidation Protein Products; Correlation of Data; Depression; Female; Humans; Male; Malondialdehyde; Mood Disorders; Nervous System; Oxidative Stress; Psychiatric Status Rating Scales; Quality of Life; Risk Factors; Thyrotropin | 2018 |